Yvette C Kluiters

Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.

Tom Dormans, M. Nijsten, J. Twisk, 2016, The Lancet. Infectious diseases.